相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow
Emine Gazi et al.
CARDIOVASCULAR JOURNAL OF AFRICA (2014)
Telmisartan prevents angiotensin II-induced endothelial dysfunction in rabbit aorta via activating HGF/Met system and PPARγ pathway
Ze-Ping Hu et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2014)
Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: Role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein
Ahmed O. Abdel-Zaher et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2014)
Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway
He Li et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor gamma
Xiao-Cong Zeng et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Endothelial Function, Oxidative Stress and Inflammatory Studies in Chronic Coronary Slow Flow Phenomenon Patients
Victoria Kopetz et al.
CARDIOLOGY (2012)
Coronary Slow Flow - Prevalence and Clinical Correlations -
Beau M. Hawkins et al.
CIRCULATION JOURNAL (2012)
Endothelial function in patients with slow coronary flow and normal coronary angiography
Luis Ulisses Signori et al.
CLINICS (2012)
Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary Drug-Eluting Stent Implantation in Hypertensive Patients
Mitsuyasu Terashima et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
Endothelial Dysfunction and Increased Carotid Intima-Media Thickness in the Patients with Slow Coronary Flow
Hyun Ju Yoon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Vascular Endothelial Function in Patients with Coronary Slow Flow and the Effects of Nebivolol
Yilmaz Gunes et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2011)
Lentiviral-Human Heme Oxygenase Targeting Endothelium Improved Vascular Function in Angiotensin II Animal Model of Hypertension
Jian Cao et al.
HUMAN GENE THERAPY (2011)
Pivotal role of inflammation in vascular endothelial dysfunction of hyperlipidemic rabbit and effects by atorvastatin
Yang Xin Chen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: A randomized, double-blind, placebo-controlled study
Francesco Pelliccia et al.
ATHEROSCLEROSIS (2010)
Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-κB pathways
Xin Liu et al.
BIOMATERIALS (2010)
Rosiglitazone Attenuates Endothelin-1-Induced Vasoconstriction by Upregulating Endothelial Expression of Endothelin B Receptor
Jianwei Tian et al.
HYPERTENSION (2010)
Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats
Minoru Satoh et al.
HYPERTENSION RESEARCH (2010)
Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan
Takehiko Wago et al.
HYPERTENSION RESEARCH (2010)
Fixed-Dose Telmisartan/Hydrochlorothiazide in Comparison With Losartan/Hydrochlorothiazide in Decreasing Serum Hepatocyte Growth Factor and Improving Endothelial Dysfunction in Hypertensive Patients
Ze-Ping Hu et al.
INTERNATIONAL HEART JOURNAL (2010)
p38 Mitogen-Activated Protein Kinase (MAPK) Increases Arginase Activity and Contributes to Endothelial Dysfunction in Corpora Cavernosa from Angiotensin-II-Treated Mice
Haroldo A. Toque et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Pioglitazone Improves Endothelial Function with Increased Adiponectin and High-density Lipoprotein Cholesterol Levels in Type 2 Diabetes
Kyoichiro Tsuchiya et al.
ENDOCRINE JOURNAL (2009)
A Selective Peroxisome Proliferator-Activated Receptor-γ Modulator, Telmisartan, Binds to the Receptor in a Different Fashion from Thiazolidinediones
Tetsuya Tagami et al.
ENDOCRINOLOGY (2009)
Decreased plasma concentrations of adiponectin in patients with slow coronary flow
Hatice Selcuk et al.
HEART AND VESSELS (2009)
The peroxisome proliferator-activated receptor-γ agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance
Christian Werner et al.
DIABETES (2007)
Rosuvastatin suppresses the inflammatory responses through inhibition of c-jun N-terminal kinase and nuclear factor-κB in endothelial cells
Yong Sook Kim et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Nanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathways
Xiao-bo Wang et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists
Yingjian Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A new signaling mechanism of hepatocyte growth factor-induced endothelial proliferation
CRW Kuhlmann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Plasma nitric oxide level and its role in slow coronary flow phenomenon
N Sezgin et al.
INTERNATIONAL HEART JOURNAL (2005)
Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells
A Uruno et al.
HYPERTENSION RESEARCH (2004)
Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow
A Çamsari et al.
CIRCULATION JOURNAL (2003)
Endothelial activation by angiotensin II through NFκB and p38 pathways:: Involvement of NFκB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin
A Costanzo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Vascular endothelial function in patients with slow coronary flow
AT Sezgin et al.
CORONARY ARTERY DISEASE (2003)
The coronary slow flow phenomenon - A new coronary microvascular disorder
JF Beltrame et al.
CARDIOLOGY (2002)
Slow coronary flow: A distinct angiographic subgroup in syndrome X
PK Goel et al.
ANGIOLOGY (2001)
Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
C Haug et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
分享论文
